Menu
Search
|

Menu

Close
X

NuVasive Inc NUVA.OQ (NASDAQ Stock Exchange Global Select Market)

55.34 USD
-- (--)
As of Mar 20
chart
Previous Close 55.34
Open --
Volume --
3m Avg Volume 248,579
Today’s High --
Today’s Low --
52 Week High 72.38
52 Week Low 43.52
Shares Outstanding (mil) 51.64
Market Capitalization (mil) 2,857.51
Forward P/E 248.07
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.63 Mean rating from 19 analysts

KEY STATS

Revenue (mm, USD)
FY18
1,102
FY17
1,027
FY16
962
EPS (USD)
FY18
0.223
FY17
1.135
FY16
0.685
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
248.07
58.82
Price to Sales (TTM)
vs sector
2.59
9.06
Price to Book (MRQ)
vs sector
3.42
4.61
Price to Cash Flow (TTM)
vs sector
20.09
40.52
Total Debt to Equity (MRQ)
vs sector
72.20
17.60
LT Debt to Equity (MRQ)
vs sector
72.20
13.95
Return on Investment (TTM)
vs sector
0.83
12.09
Return on Equity (TTM)
vs sector
1.53
13.20

EXECUTIVE LEADERSHIP

Gregory Lucier
Chairman of the Board, Since 2018
Salary: $833,649.00
Bonus: --
J. Christopher Barry
Chief Executive Officer, Director, Since 2018
Salary: --
Bonus: --
Rajesh Asarpota
Principal Financial Officer, Executive Vice President, Principal Accounting Officer, Since 2018
Salary: $134,462.00
Bonus: --
Joan Stafslien
Executive Vice President, General Counsel, Corporate Secretary, Since 2016
Salary: --
Bonus: --
Carol Cox
Executive Vice President - External Affairs and Corporate Marketing, Since 2015
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

7475 Lusk Blvd
SAN DIEGO   CA   92121-5707

Phone: +1858.9091800

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.

SPONSORED STORIES